392 - Favorable Adherence and Safety of Twice-Yearly Subcutaneous Lenacapavir for PrEP Among PURPOSE 2 Participants Who Used Substances

Presenting Author(s)

• 

  Jesse Clark

  Slides

Co-Author(s)

• 

  Allison Agwu, MD, ScM (she/her/hers)

  Professor
  Johns Hopkins University School of Medicine
  Baltimore, MD, United States
• SB

  Susan P. Buchbinder, MD

  Director Bridge HIV
  San Francisco Department of Public Health
  San Francisco, California, United States
• 

  Jill Blumenthal, MD MAS (she/her/hers)

  Professor
  University of California San Diego
  San Diego, CA, United States
• NP

  Nittaya Phanuphak, MD, PhD

  Institute of HIV Research and Innovation – Pribta Tangerine Clinic
  Bangkok, Krung Thep, Thailand
• JB

  Joanne Batting, MBChB

  Foundation for Professional Development (FPD), Ndevana Community Research Site
  Ndevana, Eastern Cape, South Africa
• 

  Michelle Cespedes, MD, MS

  Professor of Medicine
  Icahn School of Medicine at Mount Sinai; Mount Sinai Health System
  New York, NY, United States
• BG

  Beatriz Grinsztejn, MD, PhD

  Professor of Medicine
  15. Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz
  Rio de Janiero, Rio de Janeiro, Brazil
• JL

  Javier R. Lama, MD, MPH

  Director of Research
  Asociación Civil Impacta Salud y Educacion
  Lima, Lima, Peru
• 

  Karam Mounzer, MD (he/him/his)

  Clinical Professor of Medicine The Perelman School of Medicine at the University of Pennsylvania
  Philadelphia Fight Community Health Centers
  Philadelphia, Pennsylvania, United States
• PA

  Priyanka Arora, PhD

  Gilead Sciences, Inc.
  Foster City, California, United States
• 

  Lillian B. Brown, MD, PhD

  Director Clinical Development
  Gilead Sciences, Inc.
  Foster City, CA, United States
• CC

  Christoph C. Carter, MD, PhD

  Director, Clinical Research (MD)
  Gilead Sciences, Inc.
  Foster City, California, United States
• SS

  Sara Salerno, PharmD, PhD

  Gilead Sciences, Inc.
  Foster City, California, United States
• RS

  Renu Singh, PhD, MS

  Gilead Sciences, Inc.
  Foster City, California, United States
• PW

  Pamela Wong, MPH

  Associate Director of Biostatistics
  Gilead Sciences, Inc.
  Foster City, California, United States
• CH

  Carlo Hojilla, PhD

  Gilead Sciences
  Foster City, California, United States
• SD

  Susanne Doblecki-Lewis, MD, MSPH

  Professor of Clinical Medicine
  University of Miami Miller School of Medicine
  Miami, Florida, United States